Your shopping cart is empty

Subscriber login

REGISTER FOR FREE EZINES

Advanced Search

Home
Books
Conferences
Newsletters
Training
White Papers
Advertising
Contact Us
About Us

E-Zines

Check out our free and informative ezines and sign up now

Home > Newsletters > The GMP Letter > Watson Recalibrates Equipment After Fentanyl Patch Recall

The GMP Letter

September 2009

Watson Recalibrates Equipment After Fentanyl Patch Recall

Watson Pharmaceuticals has adjusted calibration for a machine that manufactures its fentanyl transdermal patches after a small number of them that leaked prompted a voluntary recall of one lot of the product.

This article is viewable by subscribers only. To view this article, please select an option below.

Subscribe
Print This Page
RSS
Free Trial
Archives
Sample PDF

Related Articles

Multi-Med Huber Needles Recalled FDA Deems Recall of Fake Mesh a Class I, Still Investigating Infusion Pump Recall Could Cost Up to $600 Million, Baxter Says FDA Orders Recall of Baxter Infusion Pumps

Home
About Us
Contact Us
Site Map
Privacy Policy

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA.
Phone (703) 538-7600 - Fax (703) 538-7676 - Toll free (888) 838-5578.

ePublishing :: CMS, Hosting & Web Development | © Copyright by FDAnews

All rights reserved. Do not duplicate or redistribute in any form.